Search Results - "Gogishvili, T"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo by Sommermeyer, D, Hudecek, M, Kosasih, P L, Gogishvili, T, Maloney, D G, Turtle, C J, Riddell, S R

    Published in Leukemia (01-02-2016)
    “…Adoptive T-cell therapy with gene-modified T cells expressing a tumor-reactive T-cell receptor or chimeric antigen receptor (CAR) is a rapidly growing field of…”
    Get full text
    Journal Article
  2. 2

    Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors by Monjezi, R, Miskey, C, Gogishvili, T, Schleef, M, Schmeer, M, Einsele, H, Ivics, Z, Hudecek, M

    Published in Leukemia (01-01-2017)
    “…Immunotherapy with T cell modified with gamma-retroviral or lentiviral (LV) vectors to express a chimeric antigen receptor (CAR) has shown remarkable efficacy…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Chimeric antigen receptor-modified T cells derived from defined [CD8.sup.+] and [CD4.sup.+] subsets confer superior antitumor reactivity in vivo by Sommermeyer, D, Hudecek, M, Kosasih, P.L, Gogishvili, T, Maloney, D.G, Turtle, C.J, Riddell, S.R

    Published in Leukemia (01-02-2016)
    “…Adoptive T-cell therapy with gene-modified T cells expressing a tumor-reactive T-cell receptor or chimeric antigen receptor (CAR) is a rapidly growing field of…”
    Get full text
    Journal Article
  6. 6

    Chimeric antigen receptor-modified T cells derived from defined CD8.sup.+ and CD4.sup.+ subsets confer superior antitumor reactivity in vivo by Kosasih, P L, Maloney, D G, Turtle, C J, Riddell, S R, Sommermeyer, D, Hudecek, M, Gogishvili, T

    Published in Leukemia (01-02-2016)
    “…Adoptive T-cell therapy with gene-modified T cells expressing a tumor-reactive T-cell receptor or chimeric antigen receptor (CAR) is a rapidly growing field of…”
    Get full text
    Journal Article
  7. 7

    Chimeric antigen receptor-modified T cells derived from defined CD8 super(+) and CD4 super(+) subsets confer superior antitumor reactivity in vivo by Sommermeyer, D, Hudecek, M, Kosasih, P L, Gogishvili, T, Maloney, D G, Turtle, C J, Riddell, S R

    Published in Leukemia (01-02-2016)
    “…Adoptive T-cell therapy with gene-modified T cells expressing a tumor-reactive T-cell receptor or chimeric antigen receptor (CAR) is a rapidly growing field of…”
    Get full text
    Journal Article
  8. 8

    Inhibition of IL-4/IL-13 does not enhance the efficacy of allergen immunotherapy in murine allergic airway inflammation by Gogishvili, Tea, Hahn, Christian, Meinhard, Julia, Hohaus, Andreas, Erb, Klaus, Sebald, Walter, Bröcker, Eva B, Grunewald, Susanne M

    “…Successful allergen-specific immunotherapy (SIT) is associated with reduced Th2 cytokine production and the induction of IL-10-producing regulatory T cells. To…”
    Get full text
    Journal Article
  9. 9